These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32767470)
1. The rational discovery of multipurpose inhibitors of the ornithine decarboxylase. Chai X; Zhan J; Pan J; He M; Li B; Wang J; Ma H; Wang Y; Liu S FASEB J; 2020 Sep; 34(9):10907-12921. PubMed ID: 32767470 [TBL] [Abstract][Full Text] [Related]
2. Induction of a protein inhibitor to ornithine decarboxylase by the end products of its reaction. Heller JS; Fong WF; Canellakis ES Proc Natl Acad Sci U S A; 1976 Jun; 73(6):1858-62. PubMed ID: 1064859 [TBL] [Abstract][Full Text] [Related]
3. Purification and Characterization of Ornithine Decarboxylase from El-Sayed ASA; George NM; Yassin MA; Alaidaroos BA; Bolbol AA; Mohamed MS; Rady AM; Aziz SW; Zayed RA; Sitohy MZ Molecules; 2019 Jul; 24(15):. PubMed ID: 31362455 [TBL] [Abstract][Full Text] [Related]
4. A Label-Free Continuous Fluorescence-Based Assay for Monitoring Ornithine Decarboxylase Activity with a Synthetic Putrescine Receptor. Nilam M; Gribbon P; Reinshagen J; Cordts K; Schwedhelm E; Nau WM; Hennig A SLAS Discov; 2017 Aug; 22(7):906-914. PubMed ID: 28346093 [TBL] [Abstract][Full Text] [Related]
5. N-ω-chloroacetyl-l-ornithine, a new competitive inhibitor of ornithine decarboxylase, induces selective growth inhibition and cytotoxicity on human cancer cells versus normal cells. Medina-Enríquez MM; Alcántara-Farfán V; Aguilar-Faisal L; Trujillo-Ferrara JG; Rodríguez-Páez L; Vargas-Ramírez AL J Enzyme Inhib Med Chem; 2015 Jun; 30(3):345-53. PubMed ID: 24939101 [TBL] [Abstract][Full Text] [Related]
6. Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat. Humphreys MH; Etheredge SB; Lin SY; Ribstein J; Marton LJ Am J Physiol; 1988 Aug; 255(2 Pt 2):F270-7. PubMed ID: 3136663 [TBL] [Abstract][Full Text] [Related]
7. Activation of ornithine decarboxylase protects against methylmercury toxicity by increasing putrescine. Sato M; Toyama T; Lee JY; Miura N; Naganuma A; Hwang GW Toxicol Appl Pharmacol; 2018 Oct; 356():120-126. PubMed ID: 30081057 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy. Geck RC; Foley JR; Murray Stewart T; Asara JM; Casero RA; Toker A J Biol Chem; 2020 May; 295(19):6263-6277. PubMed ID: 32139506 [TBL] [Abstract][Full Text] [Related]
9. Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity. Kim DJ; Roh E; Lee MH; Oi N; Lim DY; Kim MO; Cho YY; Pugliese A; Shim JH; Chen H; Cho EJ; Kim JE; Kang SC; Paul S; Kang HE; Jung JW; Lee SY; Kim SH; Reddy K; Yeom YI; Bode AM; Dong Z Cancer Res; 2016 Mar; 76(5):1146-1157. PubMed ID: 26676750 [TBL] [Abstract][Full Text] [Related]
10. DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening. Park MG; Kim SY; Lee CJ J Enzyme Inhib Med Chem; 2023 Dec; 38(1):309-318. PubMed ID: 36451618 [TBL] [Abstract][Full Text] [Related]
11. The antizyme family for regulating polyamines. Kahana C J Biol Chem; 2018 Nov; 293(48):18730-18735. PubMed ID: 30355739 [TBL] [Abstract][Full Text] [Related]
13. Regulation of polyamine homeostasis through an antizyme citrullination pathway. Yang YF; Lee CY; Hsieh JY; Liu YL; Lin CL; Liu GY; Hung HC J Cell Physiol; 2021 Aug; 236(8):5646-5663. PubMed ID: 33432662 [TBL] [Abstract][Full Text] [Related]
14. Ornithine Decarboxylase Inhibition: A Strategy to Combat Various Diseases. Somani RR; Rai PR; Kandpile PS Mini Rev Med Chem; 2018; 18(12):1008-1021. PubMed ID: 28971766 [TBL] [Abstract][Full Text] [Related]
15. Polyamine-mediated turnover of ornithine decarboxylase in Chinese-hamster ovary cells. Glass JR; Gerner EW Biochem J; 1986 Jun; 236(2):351-7. PubMed ID: 3092809 [TBL] [Abstract][Full Text] [Related]
16. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase. Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958 [TBL] [Abstract][Full Text] [Related]
17. Critical Factors in Human Antizymes that Determine the Differential Binding, Inhibition, and Degradation of Human Ornithine Decarboxylase. Hsieh JY; Liu YC; Cheng IT; Lee CJ; Wang YH; Fang YS; Liu YL; Liu GY; Hung HC Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31842334 [TBL] [Abstract][Full Text] [Related]
18. The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylmethionine decarboxylase of Plasmodium falciparum: recombinant expression and catalytic properties of two different constructs. Krause T; Lüersen K; Wrenger C; Gilberger TW; Müller S; Walter RD Biochem J; 2000 Dec; 352 Pt 2(Pt 2):287-92. PubMed ID: 11085920 [TBL] [Abstract][Full Text] [Related]
19. Early developmental profile of ornithine decarboxylase in the frog, Microhyla ornata and its regulation by polyamines. Joseph K; Baby TG J Exp Zool; 1991 May; 258(2):158-63. PubMed ID: 2022946 [TBL] [Abstract][Full Text] [Related]
20. A unified pathway for the degradation of ornithine decarboxylase in reticulocyte lysate requires interaction with the polyamine-induced protein, ornithine decarboxylase antizyme. Mamroud-Kidron E; Omer-Itsicovich M; Bercovich Z; Tobias KE; Rom E; Kahana C Eur J Biochem; 1994 Dec; 226(2):547-54. PubMed ID: 8001569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]